Merck results beat expectations as top drugs Keytruda, Gardasil post strong sales

Merck still posted a quarterly loss due to previously announced charges associated with its cancer drug collaboration deal with Daiichi Sankyo.

Previous post Merck results beat expectations as top drugs Keytruda, Gardasil post strong sales
Next post Peloton posts mixed holiday results, dismal quarterly guidance